MCRA’s Post

The largest orthopedic companies have reported 3Q earnings and noted that market trends are playing out as expected, says our Senior Market Analyst Michael Evers. 1. Surgical volumes remain elevated but have fallen off the torrid growth pace of the first half. 2. Enabling technology is playing a crucial role in joint replacement and spine sales. 3. The spine market is in a state of flux because of M&A and leadership changes. Bookmark our 3Q/9M analysis article to follow sales and market updates as public companies report. Companies covered to date: Anika, Alphatec Spine, CONMED Corporation, DePuy Synthes, Globus Medical, Smith+Nephew, Stryker, Zimmer Biomet, ZimVie #orthopedics #earningsseason #spine #jointreplacement #trauma #sportsmedicine #orthobiologics #mergersandacquisitions #roboticsurgery

📢 MAY ARTICLE EXPRESS 📃 Clinical effects of combined anteversion and offset on postoperative dislocation in total hip arthroplasty 🙋 Ryo Hidaka, Kenta Matsuda, Shigeru Nakamura, Masaki Nakamura & Hirotaka Kawano 🌟 Highlights: -To date, little is known about the effects of combined anteversion (CA) and offset on #dislocation. -We evaluated CA values after #THA and pre- and postoperative changes in offset. -We showed that the dislocation rate was significantly lower when #implants were placed within ±10% of the recommended CA value. -Our results suggest that dislocation can be avoided by placing the implant in the good CA range and considering the increase in total offset on the operative side. 👉 Full text: https://lnkd.in/gW2QUFux #Arthroplasty #orthopedics #medicalresearch

Orthopedic Study Explores Novel Surgical Techniques and Their Market Implications A recent study in orthopedic surgery explores innovative techniques that could transform patient outcomes. The study analyzes surgical advancements and their impact on clinical efficacy and market access. The research highlights minimally invasive procedures that can improve recovery times and reduce complications, potentially revolutionizing the market and lowering healthcare costs. The study also discusses the market implications and the need for streamlined approval processes to ensure new techniques can reach the market. In conclusion, the study provides valuable insights on how innovative surgical techniques can shape orthopedic care and improve patient outcomes globally. For more details please click the link! https://lnkd.in/dEsph-ed #marketaccess #reimbursement #pricing #hta #heor #healtheconomics #medicaldevices #pharmaceutical

📌 𝐍𝐏𝐏𝐀 𝐞𝐱𝐭𝐞𝐧𝐝𝐬 𝐜𝐞𝐢𝐥𝐢𝐧𝐠 𝐏𝐫𝐢𝐜𝐞 𝐅𝐢𝐱𝐚𝐭𝐢𝐨𝐧 𝐟𝐨𝐫 𝐎𝐫𝐭𝐡𝐨𝐩𝐚𝐞𝐝𝐢𝐜 𝐊𝐧𝐞𝐞 𝐈𝐦𝐩𝐥𝐚𝐧𝐭𝐬 📌 The National Pharmaceutical Pricing Authority (NPPA) has taken an important step in regulating the pricing of orthopedic knee implants for knee replacement systems. In the public interest, NPPA initially set the price ceiling on August 16, 2017, a decision that has been extended six times to date. The recent meeting of the competent authority on September 6, 2023 resulted in the extension of price ceiling fixation for another year until September 15, 2024 or until further notice, as appropriate. whichever comes first, by notice No. S.O.-4078(E )-Dt-15-09-2023. During the meeting, the NPPA thoroughly discussed various factors affecting the pricing of orthopaedic knee implants which follows: 👉 Fluctuations in foreign exchange rates. 👉 Increase in manpower costs. 👉 Rise in freight costs. 👉 Wholesale Price Index (WPI) fluctuations. 👉 Supply chain challenges. #orthopedics #medicaldeviceindustry #pricingstrategies #implants

The global Interbody Fusion Cage market was valued at US$ 2089 million in 2023 and is anticipated to reach US$ 2683.7 million by 2030 witnessing a CAGR of 3.6% during the forecast period 20242030. Johnson Johnson Medtronic Stryker Zimmer Biomet etc. are key players of global interbody fusion cage market and the top 4 players hold a share over 45% altogether. North America Europe and Asia Pacific are main segment market cover over 80% shares. Clinic is the main application which covers over 50%. #GlobalInterbodyFusionCageMarket #SpinalFusionSurgery #MedicalDevices #Healthcare #Orthopedics #Neurosurgery #DegenerativeDiscDisease #HerniatedDisc #SpinalStenosis #MinimallyInvasiveSurgery

"Does truth ultimately prevail ? History tends to say yes in medical innovations Here are some truths about the sacroiliac joint (SIJ): 1.    As the largest synovial joint in the axial skeleton, the SIJ has extensive cartilage endplates and a significant lubricant presence. 2.    The practice of using a relatively small, intra-articular device for SIJ fusion overlooks the joint's large surface area and may explain the current lack of supporting radiologic evidence. 3.    Arguing over who is technically qualified to perform SIJ fusion with implants ignores the ethical implications of inserting non-retrievable devices in patients. Sacrix, Medtronic, and SI-BONE have invented various techniques and titanium implants to transfix across the SIJ to address the fusion challenges. The Sacrix implant, for instance, features a complex multithreaded matrix design with RBM surface texturing and the technique was aimed at crossing from posteriorly to anteriorly using two implants separated from each other to increase the chance of immediate stabilization and eventual fusion. This was a lot of orthopedic engineering for a reason !! Its effectiveness has been supported by peer-reviewed publications since receiving FDA approval in 2015. https://lnkd.in/eCxgq6M5 Sacrix can be inserted percutaneously through an incision smaller than 1 inch and is retrievable by the physician. Truth is this technique can be done safely by interventional pain management, orthopedic surgeons and neurosurgeons. I hold a deep respect for all medical innovations, acknowledging that there is no perfect solution for all patients. Thanks to Vasilios Kountis, DO for his image. #sacroiliacjoint #sij #fusion #spine #fda #implant #transfix #surgeon #spine #orthopedic #neurosurgeon #interventionalpainmanagement NANISX KIC Ventures NanoFUSE Biologics FacetFuse Inspan

FDA's recently released draft guidance, Characterization of Metallic Coatings and/or Calcium Phosphate Coatings on Orthopedic Devices, is open for comment now through March 23. Once finalized, the document will establish testing guidance for devices containing metallic, calcium phosphate, or dual coatings. Learn more about some key takeaways from the new guidance and how Exponent supports clients with rigorous testing and analysis for premarket submissions: https://hubs.li/Q02lV0xr0 Ryan Siskey; Kevin Ong, Ph.D., P.E.; Derek Holyoak; Eric Ouellette; Juan Jose Paredes #Exponent #Alert #FDA #MedicalDeviceDesign #MedicalDeviceManufacturing #MedicalDevices #LifeSciences #Biomedical #Orthopedics #Implants

🦴 Rheumatology and Orthopedic News in Aiuto Pharmed 🌌 📊 Delving into the complexities of the global osteoarthritis drugs' market analysis! . 💡Exploring global market analysis which is segmenged by: 1️⃣ End User 2️⃣ Age & Gender 3️⃣ Treatment Type 4️⃣ Geographical Location 5️⃣ Industrial Key Players . 💊 By Following Aiuto Pharmed, stay updated on the latest insights and innovations in Rheumatology and Orthopedics research and development! . In Aiuto Pharmed, we strongly believe in: "Our Nation is Imagination" 🌱 . #Rheumatology #Orthopedics #Rheumatologyandorthopedics #Rheumatologynews  #Orthopedicsnews #DrugMarket #pharmaceutical #pharmaceuticalindustry #pharmaceuticalmarketresearch #pharmaceuticalmarketanalysis #pharmaceuticalmarketshare #HealthcareInnovation #AiutoNews #AiutoPharmed #osteoarthritisdrugs #osteoarthritisdrugs

According to our research the global market for medical devices is estimated at US$ 603 billion in the year 2023 and will be growing at a CAGR of 5% during next six years. #PediatricOrthopedics #OrthopedicImmobilization #ChildHealth #MedicalDevices #HealthcareIndustry #OrthopedicDevices #PediatricHealth #OrthopedicTreatment #OrthopedicRecovery #OrthopedicMarket

Per our Orthopedics M&A Tracker, 26 deals occurred through early December 2023. We expect deal volume will remain in line in the coming years. Higher input costs for buyers and the relative scarcity of high-quality, commercial-ready targets will likely keep deal volumes from appreciable growth until sometime in 2025. Our Senior Market Analyst Michael Evers reviews the M&A landscape and highlights the most active M&A companies in #orthopedics. Can you guess which companies are in the top 5? #mergersandacquisitions #strategy Enovis Smith+Nephew DePuy Synthes Zimmer Biomet OrthoPediatrics